Quick answers
- What is Tyzavan?
- Tyzavan is a brand name of Vancomycin, a prescription medicine. The FDA NDC Directory lists 7 Tyzavan products in 7 strengths and forms.
- Who makes Tyzavan?
- Hikma holds the FDA application for Tyzavan (NDA211962, approved February 15, 2019).
- Is there a generic or store brand of Tyzavan?
- Yes. The FDA NDC Directory lists 7 other products with the same active ingredients, strength and form as a Tyzavan product. Ask your pharmacist whether one is right for you.
- Has Tyzavan been recalled?
- No recall linked to Tyzavan products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Tyzavan is
Each Tyzavan product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Vancomycin · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| vancomycin 1 g/200 mL injection, solution (intravenous) | Tyzavan | 1 product, 1 company | DailyMed |
| vancomycin 1.25 g/250 mL injection, solution (intravenous) | Tyzavan | 1 product, 1 company | DailyMed |
| vancomycin 1.5 g/300 mL injection, solution (intravenous) | Tyzavan | 1 product, 1 company | DailyMed |
| vancomycin 1.75 g/350 mL injection, solution (intravenous) | Tyzavan | 1 product, 1 company | DailyMed |
| vancomycin 2 g/400 mL injection, solution (intravenous) | Tyzavan | 1 product, 1 company | DailyMed |
| vancomycin 500 mg/100 mL injection, solution (intravenous) | Tyzavan | 1 product, 1 company | DailyMed |
| vancomycin 750 mg/150 mL injection, solution (intravenous) | Tyzavan | 1 product, 1 company | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Vancomycin →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA211962 | Hikma | February 15, 2019 | 7 |
Companies that list Tyzavan
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Tyzavan products.
- Hikma Pharmaceuticals USA Inc.7 products
Recalls
No recall linked to Tyzavan products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.